Skip to content

13F-HR filed by Prosight Management, LP

Prosight Management, LP filed this 13F-HR for the quarter ended 2019-03-31, filed 2019-05-15, with 38 holding rows worth $228,559,000.

Accession
0001420506-19-000514
Filed
2019-05-15
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2019

A holdings report, 38 entries on the cover page, a total value of $228,559,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $228,559,000 with VALUE read as thousands by filing date, 13F file number 028-18450. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
Cigna Corporation125523100COM138,000$22,193,000thousands by filing date
HANGER INC41043F208COMMON STOCK933,548$17,784,000thousands by filing date
ZIMMER BIOMET HOLDINGS INC COM98956P102Stock123,500$15,771,000thousands by filing date
REATA PHARMACEUTICALS INC75615P103CL A175,700$15,017,000thousands by filing date
Bristol-Myers Squibb Company110122108COM283,000$13,502,000thousands by filing date
ARENA PHARMACEUTICALS INC040047607COM NEW252,500$11,320,000thousands by filing date
WELLCARE HEALTH PLANS INC94946T106COM40,700$10,979,000thousands by filing date
IOVANCE BIOTHERAPEUTICS INC462260100COM917,080$8,721,000thousands by filing date
ALBIREO PHARMA INC01345P106COMMON STOCK269,836$8,691,000thousands by filing date
NEVRO CORP64157F103COM128,765$8,049,000thousands by filing date
EVERFORTH INC COM00191U102Stock109,116$6,928,000thousands by filing date
ASSEMBLY BIOSCIENCES INC045396108COM314,410$6,191,000thousands by filing date
CLOVIS ONCOLOGY INC189464100COM249,389$6,190,000thousands by filing date
UROGEN PHARMA LTDM96088105COMMON STOCK157,862$5,831,000thousands by filing date
ALDEYRA THERAPEUTICS INC01438T106COM583,300$5,267,000thousands by filing date
BIOMARIN PHARMACEUTICAL INC09061G101COM57,384$5,097,000thousands by filing date
EXACT SCIENCES CORP30063P955PUT54,500$4,721,000thousands by filing dateput
STRONGBRIDGE BIOPHARMA PLCG85347105SHS USD933,876$4,651,000thousands by filing date
WAGEWORKS INC930427109COM115,926$4,377,000thousands by filing date
NEVRO CORP64157F903CALL70,000$4,375,000thousands by filing datecall
SIERRA ONCOLOGY INC82640U107COM2,457,683$4,203,000thousands by filing date
CENTENE CORP DEL COM15135B101Stock78,400$4,163,000thousands by filing date
MILLENDO THERAPEUTICS INC60040X103COM270,762$4,061,000thousands by filing date
INTEC PHARMA LTD JERUSALEMM53644106SHS542,919$3,980,000thousands by filing date
CATALYST BIOSCIENCES INC14888D208COM484,200$3,927,000thousands by filing date
AC IMMUNE SAH00263105SHS710,541$3,588,000thousands by filing date
TELIGENT INC NEW87960W104COM3,041,568$3,528,000thousands by filing date
PROVIDENCE SVC CORP743815102COM52,324$3,486,000thousands by filing date
KURA ONCOLOGY INC COM50127T109Stock172,894$2,868,000thousands by filing date
MACROGENICS INC556099109COM107,560$1,934,000thousands by filing date
MOLECULAR TEMPLATES INC608550109COM297,790$1,730,000thousands by filing date
MEIRAGTX HOLDINGS PLCG59665102COMMON STOCK91,317$1,573,000thousands by filing date
ALDEYRA THERAPEUTICS INC01438T906COM162,300$1,466,000thousands by filing datecall
UROVANT SCIENCESG9381B108COMMON STOCK99,870$1,004,000thousands by filing date
CERECOR INC15671L109COM113,835$665,000thousands by filing date
CIDARA THERAPEUTICS INC COM NEW171757107Stock220,264$584,000thousands by filing date
AQUINOX PHARMACEUTICALS INC03842B101COM28,300$76,000thousands by filing date
ENANTA PHARMACEUTICALS INC29251M106COM709$68,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001420506-19-000514this filing2019-05-15acceptance time not in the bulk data set